Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00414726 · ClinicalTrials.gov registry record · Phase 2
Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 85
- Enrollment target
NCT00414726: Clinical Trial Phase 2 study, sponsored by Massachusetts General Hospital.
NCT00414726 is a Phase 2 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 85 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00414726, a Phase 2 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy of treating individuals with acute ischemic stroke with normobaric oxygen therapy (NBO, given within 9 hours of symptom onset), to standard medical treatment.
Primary Outcome
The NIHSS score ranges from 0 (best score) to 42 (worst score).
Interventions
- DRUG Room Air
- DRUG NBO (Normobaric Oxygen)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Why NCT00414726 stopped before completion
NCT00414726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (36% lower).
The record links to 0 conditions, and to 2 interventions - of which Room Air is the first listed.
NCT00414726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00414726 about?
NCT00414726 is a clinical study titled "Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial". The purpose of this study is to compare the safety and efficacy of treating individuals with acute ischemic stroke with normobaric oxygen therapy (NBO, given within 9 hours of symptom onset), to standard medical treatment.
What is the current status of trial NCT00414726?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 85 participants. The study started on 2007-01. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00414726?
The interventions under investigation include: Room Air (DRUG), NBO (Normobaric Oxygen) (DRUG).
Who is sponsoring clinical trial NCT00414726?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00414726's enrollment target sits among peer trials
85 820th of 2000 higher than 1,179 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia